Table II.
Comparison of Two Independent PKCθ Knockout Strains
| Sun et al. (reference 14) | This study | |
|---|---|---|
| Targeting strategy: | Exon 11 replaced by PKG-neo | Cre/loxP null allele (deletion of exons 3 and 4) |
| Residual open reading frame | 365 aa | 9 aa |
| Thymocytes: | ||
| Development | normal | normal |
| Peripheral T cells: | ||
| Proliferative responses | ||
| to CD3/CD28 | impaired | impaired |
| to PMA/ionomycin | impaired | normal |
| to allogenic MHC | partially impaired | partially impaired |
| IL-2 production | ||
| to CD3/CD28 | impaired | impaired |
| to PMA/ionomycin | impaired | normal |
| Heterozygous phenotype: | impaired | normal |
| EMSA/stimulated with CD3/CD28 | ||
| NF-κB | impaired | partially impaired |
| AP-1 | impaired | partially impaired |
| NFAT | normal | impaired |
| Surface expression/stimulated with CD3/CD28 | ||
| CD69 | impaired | normal |
| CD25 | impaired | normal |